Merck Serono first to launch application for Haselmeier's Axis-D injection pen
2 October 2011
Merck Serono has launched the first application of the Axis-D pen platform comissioned from Swiss company Haselmeier. The new injection device has been designed to allow self injection by patients of a ready-to-use biopharmaceutical solution for injection.
Haselmeier's Axis-D Pen System is a disposable, variable-dose injection device designed for use with a 3ml cartridge.
Volker Wirth, Director Business Development & Marketing at Haselmeier, said, “With the Axis pen platform it is easy to tailor the injection device to various needs. Following our client’s specifications, we have developed a device that enables users to adjust the volume of the injection and reuse the pen several times until the cartridge is empty. For security reasons, we added a function to the pen to immediately confirm that a complete dose was delivered, or to indicate the missing amount if an incomplete dose is injected.”
The Axis pen platform is available as a reusable or disposable multi-use pen which features adjustable dosing. The pen design is based on an innovative technology featuring a sliding dose window which allows easy reading of the dose and provides reduced risk of incorrect dosing. Available in metal or plastic, the Axis pen is compatible with 3ml cartridges, all fill volumes and can be customized to meet any patient needs.